Table 2.
Mean ± (SEM) | ANOVA Repeated Measures | One-Way ANOVA | |||
---|---|---|---|---|---|
Dependent variable | TSB (n = 16) |
PMR (n = 19) |
CWL (n = 15) |
“Effect” (F) * p |
(F) * p |
RMSSD (T1) | 35.2 (3.55) | 36.19 (3.04) | 34.81 (3.63) | “Treatment” (3.6) * 0.04 “Time × treatment” (4.2) * 0.001 Figure 3A |
|
RMSSD (T2) | 36.54 (5.17) | 32 (2.20) | 30.5 (2.50) | ||
RMSSD (T3) | 48.4 (5.81) | 34.07 (2.04) | 29.4 (2.30) | (8.0) * 0.001 | |
RMSSD (T4) | 42.02 (2.78) | 37.12 (2.76) | 28.3 (2.65) | (6.5) * 0.003 | |
pNN50 (T1) | 14.7 (2.69) | 12.05 (2.33) | 19.90 (3.4) | “Time × treatment” (5.2) * 0.001 |
|
pNN50 (T2) | 16.5 (3.7) | 8.84 (2.30) | 10.8 (2.2) | ||
pNN50 (T3) | 29.05 (5.55) | 10.2 (2.73) | 16.74 (4.77) | ||
pNN50 (T4) | 16.94 (2.06) | 16.16 (3.04) | 14.62 (4.4) | ||
HRV-HF(log) (T1) | 6.3 (0.11) | 6.21 (0.07) | 6.14 (0.15) | “Treatment” (7.4) * 0.002 Figure 3B |
|
HRV-HF(log) (T2) | 6.51 (0.3) | 6.28 (0.47) | 6.07 (0.08) | ||
HRV-HF(log) (T3) | 6.87 (0.23) | 6.16 (0.22) | 6.08 (0.14) | (8.5) * 0.001 | |
HRV-HF(log) (T4) | 6.76 (0.22) | 6.33 (0.15) | 6.14 (0.12) | (8.3) * 0.001 | |
Alpha (T1) | 0.01 (0.0013) | 0.009 (0.0011) | 0.007 (0.0012) | “Time × treatment” (4.9) * 0.001 Figure 3C |
|
Alpha (T2) | 0.007 (0.0013) | 0.008 (0.0013) | 0.008 (0.0014) | ||
Alpha (T3) | 0.006 (0.001) | 0.007 (0.0011) | 0.008 (0.0016) | ||
Alpha (T3) | 0.006 (0.001) | 0.007 (0.0011) | 0.008 (0.0012) | ||
Alpha (T1–T2) | 0.0028 (0.0005) | 0.0011 (0.0007) | 0.0013 (0.0008) | (3.9) * 0.03 | |
Alpha (T1–T3) | 0.0039 (0.0006) | 0.002 (0.0006) | 0.0003 (0.0006) | (8.0) * 0.001 | |
Alpha (T1–T4) | 0.0034 (0.0005) | 0.0019 (0.0006) | 0.0001 (0.0005) | (8.4) * 0.001 Figure 3D |
|
SAI-1 | 44.94 (1.1) | 47.3 (1.7) | 46.3 (0.82) | “Treatment” (9.2) * 0.001 “Time × treatment” (11.61) * 0.001 Figure 3E |
|
SAI-2 | 35.37 (0.27) | 40.0 (0.78) | 44.8 (0.80) | (45.9) * 0.001 | |
SAI-R | 9.56 (1.1) | 7.68 (1.3) | 1.73 (0.85) | (11.6) * 0.001 Figure 3F |